Genzyme shares rising on Sanofi merger talks
Shares of Genzyme (Nasdaq: GENZ) have moved up this morning after the biotech drugmaker reported that merger talks with French Sanofi-Aventis (NYSE: SNY) have expanded.
As of 10:04 a.m. (EDT), Genzyme shares have risen 1.69 percent.
Genzyme previously rejected an $18-5-billion takeover bid by Sanofi.
© Copyright IBTimes 2024. All rights reserved.
Join the Discussion
Editor's pick